Clinical Trial Update: Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL [Phase 2]

View source ↗

Summary

Phase 2 trial investigating blinatumomab as a bridge to allogeneic hematopoietic stem cell transplantation in relapsed/refractory B-cell acute lymphoblastic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN